IL-31 induces antitumor immunity in breast carcinoma

BACKGROUND: Immunomodulatory agents that induce antitumor immunity have great potential for treatment of cancer. We have previously shown that interleukin (IL)-31, a proinflammatory cytokine from the IL-6 family, acts as an antiangiogenic agent. Here, we characterize the immunomodulatory effect of I...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Kan, Tal, Feldman, Erik, Timaner, Michael, Raviv, Ziv, Shen-Orr, Shai, Aronheim, Ami, Shaked, Yuval
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Basic Tumor Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7449545/
https://ncbi.nlm.nih.gov/pubmed/32843492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001010
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados